Alkem Laboratories Ltd. has announced the launch of Renocia Exo™, a next-generation hair regeneration therapy designed to support hair follicle health and vitality through a multi-targeted approach to hair loss management. The company describes the product as India’s first patented ginsenoside exosome-based hair growth serum.
The newly launched formulation draws on concepts from regenerative dermatology and combines ginsenoside phyto-exosomes, biomimetic peptides, copper peptides and stem cell-supportive actives. According to Alkem, the combination is intended to support follicular vitality, scalp health and the natural hair growth cycle rather than focusing solely on visible hair growth.
Hair loss is becoming an increasingly common dermatological concern in India, affecting both ageing adults and younger individuals. Genetic factors, lifestyle changes, environmental stressors and changing health patterns can contribute to hair thinning and loss. Alkem noted that the underlying biology of hair loss involves multiple interconnected processes, making a broader approach to follicular health important.
Commenting on the launch, Sandeep Singh, Managing Director, Alkem, said the understanding of progressive hair thinning has evolved considerably over the past decade. He highlighted factors such as follicular miniaturization, changes in cellular signalling, oxidative stress, inflammation and alterations in the follicular microenvironment as processes associated with hair loss.
According to the company, Renocia Exo™ has been developed to address several of these interconnected processes by supporting biological signalling pathways involved in hair follicle activity and helping create a favourable environment for healthier and stronger hair over time.
The serum has also been formulated with a lightweight and cosmetically elegant composition. Alkem states that it is free from alcohol, sulphates, silicones, parabens and mineral oil, and is intended for regular use as part of dermatologist-guided hair loss management.
The launch further expands Alkem’s presence in the dermatology segment as the company looks to incorporate emerging scientific approaches into its portfolio. With Renocia Exo™, Alkem aims to provide a regenerative-focused option that addresses the broader biology of the hair follicle alongside hair growth
